Answers are grounded in this paper and cite their sources.
Derived from this small pilot study, adjunctive aripiprazole does not seem to be a promising strategy for the acute treatment of bipolar depression. However, this lack of additional benefit seems to stem from the already good effectiveness of the control group, namely the treatment with citalopram.
No takes yet. Share an insight, caveat, or question.
Quante et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: